| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR2B
|
activin A receptor, type IIB
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
AFP
|
alpha-fetoprotein
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALX4
|
ALX homeobox 4
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
AMER2
|
APC membrane recruitment protein 2
|
|
AMH
|
anti-Mullerian hormone
|
|
ANXA5
|
annexin A5
|
|
APC
|
adenomatous polyposis coli
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3A_B
|
APOBEC3A and APOBEC3B deletion hybrid
|
|
APRT
|
adenine phosphoribosyltransferase
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF3
|
activating transcription factor 3
|
|
ATG4B
|
autophagy related 4B, cysteine peptidase
|
|
ATN1
|
atrophin 1
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
|
BBS9
|
Bardet-Biedl syndrome 9
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCOR
|
BCL6 corepressor
|
|
BCORL1
|
BCL6 corepressor-like 1
|
|
BCR
|
breakpoint cluster region
|
|
BCS1L
|
BC1 (ubiquinol-cytochrome c reductase) synthesis-like
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BLCAP
|
bladder cancer associated protein
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
BUB3
|
BUB3 mitotic checkpoint protein
|
|
C17ORF97
|
chromosome 17 open reading frame 97
|
|
CA9
|
carbonic anhydrase IX
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CCN1
|
cellular communication network factor 1
|
|
CCN2
|
cellular communication network factor 2
|
|
CCNA1
|
cyclin A1
|
|
CCND1
|
cyclin D1
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD24
|
CD24 molecule
|
|
CD274
|
CD274 molecule
|
|
CD2AP
|
CD2-associated protein
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD80
|
CD80 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH13
|
cadherin 13
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CDX1
|
caudal type homeobox 1
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEP57
|
centrosomal protein 57kDa
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIB2
|
calcium and integrin binding family member 2
|
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLYBL
|
citrate lyase beta like
|
|
CMIP
|
c-Maf inducing protein
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CRLS1
|
cardiolipin synthase 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTR9
|
CTR9, Paf1/RNA polymerase II complex component
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDX1
|
DEAD (Asp-Glu-Ala-Asp) box helicase 1
|
|
DEK
|
DEK proto-oncogene
|
|
DES
|
desmin
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIS3L2
|
DIS3 like 3'-5' exoribonuclease 2
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLG2
|
discs, large homolog 2 (Drosophila)
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DMRT3
|
doublesex and mab-3 related transcription factor 3
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DTX4
|
deltex 4, E3 ubiquitin ligase
|
|
E2F3
|
E2F transcription factor 3
|
|
EFS
|
embryonal Fyn-associated substrate
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EGR2
|
early growth response 2
|
|
EGR3
|
early growth response 3
|
|
ELP4
|
elongator acetyltransferase complex subunit 4
|
|
EMG1
|
EMG1 N1-specific pseudouridine methyltransferase
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
FAM127A
|
family with sequence similarity 127, member A
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FBXW8
|
F-box and WD repeat domain containing 8
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FH
|
fumarate hydratase
|
|
FIBP
|
fibroblast growth factor (acidic) intracellular binding protein
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLII
|
flightless I homolog (Drosophila)
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FN1
|
fibronectin 1
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
FZD1
|
frizzled class receptor 1
|
|
FZD5
|
frizzled class receptor 5
|
|
FZD7
|
frizzled class receptor 7
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLIPR1
|
GLI pathogenesis-related 1
|
|
GLRA2
|
glycine receptor, alpha 2
|
|
GPC3
|
glypican 3
|
|
GPC4
|
glypican 4
|
|
GUSB
|
glucuronidase, beta
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HBB
|
hemoglobin, beta
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC5
|
histone deacetylase 5
|
|
HDAC6
|
histone deacetylase 6
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HOXB4
|
homeobox B4
|
|
HOXD10
|
homeobox D10
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
IBTK
|
inhibitor of Bruton agammaglobulinemia tyrosine kinase
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
INTS2
|
integrator complex subunit 2
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRX3
|
iroquois homeobox 3
|
|
IRX5
|
iroquois homeobox 5
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF15
|
Kruppel-like factor 15
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLHL2
|
kelch-like family member 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT20
|
keratin 20, type I
|
|
KRT7
|
keratin 7, type II
|
|
LAMB2
|
laminin, beta 2 (laminin S)
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX1
|
LIM homeobox 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LSAMP
|
limbic system-associated membrane protein
|
|
LUZP2
|
leucine zipper protein 2
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
|
MARCKSL1
|
MARCKS-like 1
|
|
MAX
|
MYC associated factor X
|
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEIS1
|
Meis homeobox 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP1
|
microfibrillar-associated protein 1
|
|
MIA
|
melanoma inhibitory activity
|
|
MIB1
|
mindbomb E3 ubiquitin protein ligase 1
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MPZ
|
myelin protein zero
|
|
MRC1
|
mannose receptor, C type 1
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSX1
|
msh homeobox 1
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MVP
|
major vault protein
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAP1L4
|
nucleosome assembly protein 1-like 4
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCKIPSD
|
NCK interacting protein with SH3 domain
|
|
NCOA6
|
nuclear receptor coactivator 6
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NES
|
nestin
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies)
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX6-1
|
NK6 homeobox 1
|
|
NNAT
|
neuronatin
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOTCH1
|
notch 1
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX4
|
NADPH oxidase 4
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPY
|
neuropeptide Y
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPN1SW
|
opsin 1 (cone pigments), short-wave-sensitive
|
|
OSR1
|
odd-skipped related transciption factor 1
|
|
PAF1
|
Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PBX2
|
pre-B-cell leukemia homeobox 2
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHF2
|
PHD finger protein 2
|
|
PHF21A
|
PHD finger protein 21A
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLXNA1
|
plexin A1
|
|
PMEL
|
premelanosome protein
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PODXL
|
podocalyxin-like
|
|
PON1
|
paraoxonase 1
|
|
POU6F2
|
POU class 6 homeobox 2
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPP1R2P9
|
protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PRAM1
|
PML-RARA regulated adaptor molecule 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRM1
|
protamine 1
|
|
PROM1
|
prominin 1
|
|
PRTN3
|
proteinase 3
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTN
|
pleiotrophin
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPA
|
protein phosphatase 2 phosphatase activator
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
QPRT
|
quinolinate phosphoribosyltransferase
|
|
QRSL1
|
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1
|
|
RAB40B
|
RAB40B, member RAS oncogene family
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
|
|
RB1
|
retinoblastoma 1
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RBP2
|
retinol binding protein 2, cellular
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RGS6
|
regulator of G-protein signaling 6
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RNF40
|
ring finger protein 40, E3 ubiquitin protein ligase
|
|
RNMT
|
RNA (guanine-7-) methyltransferase
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPL10
|
ribosomal protein L10
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAT2
|
spermidine/spermine N1-acetyltransferase family member 2
|
|
SCT
|
secretin
|
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETBP1
|
SET binding protein 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SGSM3
|
small G protein signaling modulator 3
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SIX1
|
SIX homeobox 1
|
|
SIX2
|
SIX homeobox 2
|
|
SIX3
|
SIX homeobox 3
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A18
|
solute carrier family 22, member 18
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC38A2
|
solute carrier family 38, member 2
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMR3B
|
submaxillary gland androgen regulated protein 3B
|
|
SMTN
|
smoothelin
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOSTDC1
|
sclerostin domain containing 1
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRY
|
sex determining region Y
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
SYNPO
|
synaptopodin
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCN2
|
transcobalamin II
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TES
|
testin LIM domain protein
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TH
|
tyrosine hydroxylase
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THOP1
|
thimet oligopeptidase 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRIP13
|
thyroid hormone receptor interactor 13
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSG101
|
tumor susceptibility 101
|
|
TSPAN7
|
tetraspanin 7
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTK
|
TTK protein kinase
|
|
TTN
|
titin
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
UVRAG
|
UV radiation resistance associated
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VPS4B
|
vacuolar protein sorting 4 homolog B (S. cerevisiae)
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
WLS
|
wntless Wnt ligand secretion mediator
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
WTIP
|
Wilms tumor 1 interacting protein
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XPO5
|
exportin 5
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZFPM2
|
zinc finger protein, FOG family member 2
|
|
ZNF224
|
zinc finger protein 224
|
